See edotreotide on Wiktionary
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "",
"3": "-reotide",
"t2": "somatostatin receptor agonist/antagonist"
},
"expansion": "[Term?] + -reotide (“somatostatin receptor agonist/antagonist”)",
"name": "af"
}
],
"etymology_text": "From [Term?] + -reotide (“somatostatin receptor agonist/antagonist”).",
"head_templates": [
{
"args": {
"1": "-"
},
"expansion": "edotreotide (uncountable)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
{
"kind": "other",
"name": "English entries with incorrect language header",
"parents": [
"Entries with incorrect language header",
"Entry maintenance"
],
"source": "w"
},
{
"kind": "other",
"name": "English terms suffixed with -reotide",
"parents": [],
"source": "w"
},
{
"kind": "other",
"name": "Pages with 1 entry",
"parents": [],
"source": "w"
},
{
"kind": "other",
"name": "Pages with entries",
"parents": [],
"source": "w"
},
{
"kind": "topical",
"langcode": "en",
"name": "Pharmaceutical drugs",
"orig": "en:Pharmaceutical drugs",
"parents": [
"Drugs",
"Matter",
"Pharmacology",
"Chemistry",
"Nature",
"Biochemistry",
"Medicine",
"Sciences",
"All topics",
"Biology",
"Healthcare",
"Fundamental",
"Health",
"Body"
],
"source": "w"
}
],
"glosses": [
"A substance which, when bound to various radionuclides, is used in the treatment and diagnosis of certain cancers."
],
"id": "en-edotreotide-en-noun--cOBRciQ",
"links": [
[
"pharmacology",
"pharmacology"
],
[
"substance",
"substance"
],
[
"radionuclide",
"radionuclide"
],
[
"treatment",
"treatment"
],
[
"diagnosis",
"diagnosis"
],
[
"cancer",
"cancer"
]
],
"raw_glosses": [
"(pharmacology) A substance which, when bound to various radionuclides, is used in the treatment and diagnosis of certain cancers."
],
"tags": [
"uncountable"
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"edotreotide"
]
}
],
"word": "edotreotide"
}
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "",
"3": "-reotide",
"t2": "somatostatin receptor agonist/antagonist"
},
"expansion": "[Term?] + -reotide (“somatostatin receptor agonist/antagonist”)",
"name": "af"
}
],
"etymology_text": "From [Term?] + -reotide (“somatostatin receptor agonist/antagonist”).",
"head_templates": [
{
"args": {
"1": "-"
},
"expansion": "edotreotide (uncountable)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
"English entries with incorrect language header",
"English lemmas",
"English nouns",
"English term requests",
"English terms suffixed with -reotide",
"English uncountable nouns",
"Pages with 1 entry",
"Pages with entries",
"en:Pharmaceutical drugs"
],
"glosses": [
"A substance which, when bound to various radionuclides, is used in the treatment and diagnosis of certain cancers."
],
"links": [
[
"pharmacology",
"pharmacology"
],
[
"substance",
"substance"
],
[
"radionuclide",
"radionuclide"
],
[
"treatment",
"treatment"
],
[
"diagnosis",
"diagnosis"
],
[
"cancer",
"cancer"
]
],
"raw_glosses": [
"(pharmacology) A substance which, when bound to various radionuclides, is used in the treatment and diagnosis of certain cancers."
],
"tags": [
"uncountable"
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"edotreotide"
]
}
],
"word": "edotreotide"
}
Download raw JSONL data for edotreotide meaning in All languages combined (1.3kB)
This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2025-01-13 from the enwiktionary dump dated 2025-01-01 using wiktextract (4ba5975 and 4ed51a5). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.
If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.